Newton, Massachusetts, July 8, 2025 – PharmaVoice, in collaboration with its award-winning content studio studioID, has released a new on-demand webinar highlighting GlaxoSmithKline’s (GSK) innovative approaches to minimizing risks in drug development. Titled “Unlocking Drug Success: How GSK De-risks Drug Development,” the webinar offers insights into GSK’s strategies that enhance the efficiency and safety of drug development through early investment in claims data. The webinar demonstrates how GSK gains crucial insights into treatment dynamics in the early stages of development through novel analysis of claims data. This approach differs significantly from traditional workflows, enabling early identification and minimization of risks. Key content includes: “The webinar offers valuable insights into how GSK is transforming drug development through data-driven approaches,” explained a spokesperson for studioID. “The strategies presented are not only relevant for large pharmaceutical companies, but…

Cleveland, Ohio, July 8, 2025 – MediView XR, Inc., a leader in medical imaging technology, announced the enrollment of the first patient in a clinical trial investigating the efficacy of its XR90 Holographic Surgical Navigation System for percutaneous tumor biopsies. The study, titled “Clinical Evaluation of an Intra-procedural 3D Needle Guidance Platform for Performing Percutaneous Soft Tissue Tumor Biopsy as an Adjunct to Standard Image Guidance,” is being conducted in collaboration with renowned institutions including NewYork-Presbyterian/Weill Cornell Medical Center, MedStar Georgetown University Hospital, and MedStar Washington Hospital Center. The multicenter study, which has received IRB approval, plans to enroll 104 patients over the next 24 months. The objective is to evaluate the procedural efficiency of the XR90 system as an adjunct to standard imaging techniques such as ultrasound and CT, compared to standard imaging alone. The investigation aims to… 

London, July 8, 2025 – Six new projects to tackle food inequality in the UK were unveiled today by UK Research and Innovation (UKRI). The initiatives aim to improve the availability and affordability of nutritious food and reduce food insecurity in communities most affected. The projects, funded under UKRI’s ‘Create, Grow, Innovate’ theme, are implementing innovative approaches including: The projects respond to alarming figures: Between 2023 and 2024, 7.5 million people lived in food insecure households per month – an increase of 300,000 from 2022 and 2.5 million since 2019. Low-income households and people with disabilities are disproportionately affected. “These innovative projects from Wales to Dundee and Nottingham to the Isle of Wight will be crucial in tackling food inequalities,” said Professor Alison Park, UKRI’s Create, Grow, Innovate theme lead. Science and Technology Minister Peter Kyle added, “No one should be without access… 

Bethesda, Maryland, July 8, 2025 – The National Institutes of Health (NIH) today announced a new policy that will cap the fees publishers can charge NIH-funded scientists for publishing their research findings, starting in fiscal year 2026. This measure aims to curb exorbitant publication costs, promote scientific transparency, and strengthen public trust in public health. “An open, honest, and transparent research environment is crucial for restoring public trust,” stated NIH Director Dr. Jay Bhattacharya. “This reform not only makes science accessible to the general public but also removes financial incentives that harm taxpayers.” Currently, some publishers charge up to $13,000 per article for immediate open access and additionally collect high subscription fees from agencies. For example, the NIH pays over two million dollars annually in subscriptions and an additional ten million dollars in...